-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, C7+e4furxxoMOJVYQpvCIQpSnh54ljeoFWDQrkkTCLmC8iWtN2o5aUSwx2gWJ+fF c5mKkoabejH6YTT9XMXvUw== 0000310158-03-000003.txt : 20030121 0000310158-03-000003.hdr.sgml : 20030120 20030121153914 ACCESSION NUMBER: 0000310158-03-000003 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20030117 ITEM INFORMATION: Financial statements and exhibits ITEM INFORMATION: FILED AS OF DATE: 20030121 FILER: COMPANY DATA: COMPANY CONFORMED NAME: SCHERING PLOUGH CORP CENTRAL INDEX KEY: 0000310158 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 221918501 STATE OF INCORPORATION: NJ FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-06571 FILM NUMBER: 03519544 BUSINESS ADDRESS: STREET 1: ONE GIRALDA FARMS CITY: MADISON STATE: NJ ZIP: 07940-1000 BUSINESS PHONE: 9738227000 8-K 1 eightkform.htm SECURITIES AND EXCHANGE COMMISSION

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

January 17, 2003

Date of Report (Date of Earliest Event Reported)

Schering-Plough Corporation

(Exact name of registrant as specified in its charter)

 

New Jersey

(State or other jurisdiction of incorporation)

1-6571

(Commission File Number)

22-1918501

(IRS Employer
Identification Number)

2000 Galloping Hill Road Kenilworth, NJ 07033

(Address of principal executive offices, including Zip Code)

(908) 298-4000

(Registrant's telephone number, including area code)

Item 7. Financial Statements and Exhibits.

(c) Exhibits. The following exhibits are filed with the 8-K:

99.1 Press Release issued by Schering-Plough Corporation dated January 21, 2003 titled "Schering- Plough Announces Doliveux Resignation"

Item 9. Regulation FD Disclosure.

Moody's Rating Action

On January 17, 2003, Moody's Investors Service announced its downgrade of its rating for Schering-Plough Corporation long-term senior debt securities under its shelf registration to (P)A1 from (P)Aa2, stated that the rating outlook is stable and confirmed its rating for Schering-Plough short term debt securities of Prime -1.

Resignation of Roch Doliveux as President of Schering-Plough International

Schering-Plough Corporation January 21, 2003 issued a press release titled "Schering-Plough Announces Doliveux Resignation" stating that Roch F. Doliveux will be resigning his position as president of Schering-Plough International, effective January 31, 2003, to explore new business opportunities that may allow him to be closer to his family. The press release is attached to this 8-K as Exhibit 99.1.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Schering-Plough Corporation

 

 

 

By: /s/ Thomas H. Kelly

Thomas H. Kelly

Vice President and Controller

Date: January 21, 2003

Exhibit Index

The following exhibits are filed with this 8-K:

99.1 Press Release dated January 21, 2003 titled "Schering-Plough Announces Doliveux Resignation"

 

 

 

 

 

 

 

 

EX-99.1 3 pressrel2.htm Exhibit 99

Exhibit 99.1

 

SCHERING-PLOUGH CORPORATION

SCHERING-PLOUGH PRESS RELEASE

THE FOLLOWING PRESS RELEASE WAS ISSUED TODAY BY CORPORATE COMMUNICATIONS:

SCHERING-PLOUGH ANNOUNCES DOLIVEUX RESIGNATION

KENILWORTH, N.J., Jan. 21, 2003 - Schering-Plough Corporation (NYSE: SGP) today reported that Roch F. Doliveux will be resigning his position as president of Schering-Plough International, effective Jan. 31, 2003, to explore new business opportunities that may allow him to be closer to his family.

"We understand his wanting to be near his family and respect his decision," said Richard Jay Kogan, president and chief executive officer. "We are all grateful to Roch for his many contributions to the success of our company."

Doliveux joined Schering-Plough in 1990 and was appointed to his current position in 2000. The company said that Thomas C. Lauda, executive vice president, Schering-Plough Pharmaceuticals, will assume Doliveux' responsibilities on an interim basis in addition to his current duties, which include global marketing and worldwide business development.

Schering-Plough is a research-based company engaged in the discovery, development, manufacturing and marketing of pharmaceutical products worldwide.

 

 

-----END PRIVACY-ENHANCED MESSAGE-----